GB0019226D0 - Novel pharmaceutical - Google Patents

Novel pharmaceutical

Info

Publication number
GB0019226D0
GB0019226D0 GBGB0019226.0A GB0019226A GB0019226D0 GB 0019226 D0 GB0019226 D0 GB 0019226D0 GB 0019226 A GB0019226 A GB 0019226A GB 0019226 D0 GB0019226 D0 GB 0019226D0
Authority
GB
United Kingdom
Prior art keywords
novel pharmaceutical
pharmaceutical
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0019226.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB0019226.0A priority Critical patent/GB0019226D0/en
Publication of GB0019226D0 publication Critical patent/GB0019226D0/en
Priority to EP01954161A priority patent/EP1307448A1/fr
Priority to CA002417828A priority patent/CA2417828A1/fr
Priority to AU2001276508A priority patent/AU2001276508A1/en
Priority to CN01815682A priority patent/CN1458930A/zh
Priority to APAP/P/2003/002737A priority patent/AP2003002737A0/en
Priority to BR0112984-8A priority patent/BR0112984A/pt
Priority to MXPA03001086A priority patent/MXPA03001086A/es
Priority to EA200300231A priority patent/EA200300231A1/ru
Priority to KR10-2003-7001605A priority patent/KR20030022356A/ko
Priority to SK145-2003A priority patent/SK1452003A3/sk
Priority to PL01360702A priority patent/PL360702A1/xx
Priority to CZ2003314A priority patent/CZ2003314A3/cs
Priority to US10/343,870 priority patent/US20040102485A1/en
Priority to IL15427701A priority patent/IL154277A0/xx
Priority to JP2002518208A priority patent/JP2004505971A/ja
Priority to HU0300770A priority patent/HUP0300770A2/hu
Priority to OA1200300029A priority patent/OA12355A/en
Priority to PCT/GB2001/003514 priority patent/WO2002012233A1/fr
Priority to NO20030508A priority patent/NO20030508L/no
Priority to MA27022A priority patent/MA25830A1/fr
Priority to EC2003004468A priority patent/ECSP034468A/es
Priority to ZA200300962A priority patent/ZA200300962B/en
Priority to BG107605A priority patent/BG107605A/bg
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
GBGB0019226.0A 2000-08-04 2000-08-04 Novel pharmaceutical Ceased GB0019226D0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
GBGB0019226.0A GB0019226D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003514 WO2002012233A1 (fr) 2000-08-04 2001-08-03 Sels de tartrate de derive de thiazolidinedione
SK145-2003A SK1452003A3 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative
CZ2003314A CZ2003314A3 (cs) 2000-08-04 2001-08-03 Derivát thiazolidindionu ve formě soli kyseliny vinné
AU2001276508A AU2001276508A1 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative
CN01815682A CN1458930A (zh) 2000-08-04 2001-08-03 噻唑烷二酮衍生物的酒石酸盐
APAP/P/2003/002737A AP2003002737A0 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivatives
BR0112984-8A BR0112984A (pt) 2000-08-04 2001-08-03 Sais tartarato de derivado de tiazolidinodiona
MXPA03001086A MXPA03001086A (es) 2000-08-04 2001-08-03 Compuesto farmaceutico novedoso.
EA200300231A EA200300231A1 (ru) 2000-08-04 2001-08-03 Тартратные соли производного тиазолидиндиона
KR10-2003-7001605A KR20030022356A (ko) 2000-08-04 2001-08-03 티아졸리딘디온 유도체의 타르타르산염
EP01954161A EP1307448A1 (fr) 2000-08-04 2001-08-03 Sels de tartrate de derive de thiazolidinedione
PL01360702A PL360702A1 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative
CA002417828A CA2417828A1 (fr) 2000-08-04 2001-08-03 Sels de tartrate de derive de thiazolidinedione
US10/343,870 US20040102485A1 (en) 2000-08-04 2001-08-03 Tartrate salt of thiazolidinedione derivative
IL15427701A IL154277A0 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative
JP2002518208A JP2004505971A (ja) 2000-08-04 2001-08-03 チアゾリジンジオン誘導体の酒石酸塩
HU0300770A HUP0300770A2 (hu) 2000-08-04 2001-08-03 Tiazolidindion-származék tartarátsója
OA1200300029A OA12355A (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative.
NO20030508A NO20030508L (no) 2000-08-04 2003-01-31 Tartratsalter av tiazolidindionderivater
MA27022A MA25830A1 (fr) 2000-08-04 2003-02-03 Sel de tartrate d'un derive de thiazolidinedione.
EC2003004468A ECSP034468A (es) 2000-08-04 2003-02-04 Compuesto farmaceutico novedoso
ZA200300962A ZA200300962B (en) 2000-08-04 2003-02-04 Tartrate salts of thiazolidinedione derivative.
BG107605A BG107605A (bg) 2000-08-04 2003-02-28 Тартаратни соли на тиазолидиндионово производно

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0019226.0A GB0019226D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
GB0019226D0 true GB0019226D0 (en) 2000-09-27

Family

ID=9897028

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0019226.0A Ceased GB0019226D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical

Country Status (23)

Country Link
EP (1) EP1307448A1 (fr)
JP (1) JP2004505971A (fr)
KR (1) KR20030022356A (fr)
CN (1) CN1458930A (fr)
AP (1) AP2003002737A0 (fr)
AU (1) AU2001276508A1 (fr)
BG (1) BG107605A (fr)
BR (1) BR0112984A (fr)
CA (1) CA2417828A1 (fr)
CZ (1) CZ2003314A3 (fr)
EA (1) EA200300231A1 (fr)
EC (1) ECSP034468A (fr)
GB (1) GB0019226D0 (fr)
HU (1) HUP0300770A2 (fr)
IL (1) IL154277A0 (fr)
MA (1) MA25830A1 (fr)
MX (1) MXPA03001086A (fr)
NO (1) NO20030508L (fr)
OA (1) OA12355A (fr)
PL (1) PL360702A1 (fr)
SK (1) SK1452003A3 (fr)
WO (1) WO2002012233A1 (fr)
ZA (1) ZA200300962B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
FR2845602B1 (fr) * 2002-10-11 2005-07-08 Servier Lab Association entre un ligand des recepteurs actives par les proliferateurs de peroxisomes et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
US7264813B2 (en) * 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102532122B (zh) * 2010-12-29 2015-12-02 开封制药(集团)有限公司 酒石酸罗格列酮的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
AU2001276508A1 (en) 2002-02-18
OA12355A (en) 2004-03-19
WO2002012233A1 (fr) 2002-02-14
CA2417828A1 (fr) 2002-02-14
CN1458930A (zh) 2003-11-26
SK1452003A3 (en) 2004-05-04
ECSP034468A (es) 2003-03-31
EA200300231A1 (ru) 2003-06-26
NO20030508L (no) 2003-03-20
NO20030508D0 (no) 2003-01-31
IL154277A0 (en) 2003-09-17
EP1307448A1 (fr) 2003-05-07
MXPA03001086A (es) 2003-05-27
BR0112984A (pt) 2003-06-10
JP2004505971A (ja) 2004-02-26
KR20030022356A (ko) 2003-03-15
PL360702A1 (en) 2004-09-20
ZA200300962B (en) 2003-10-29
AP2003002737A0 (en) 2003-03-31
HUP0300770A2 (hu) 2003-11-28
MA25830A1 (fr) 2003-07-01
BG107605A (bg) 2003-09-30
CZ2003314A3 (cs) 2004-02-18

Similar Documents

Publication Publication Date Title
GB0006133D0 (en) Novel pharmaceutical
GB0025473D0 (en) Pharmaceutical combinations
GB0020691D0 (en) Pharmaceutical combination
GB0031084D0 (en) Pharmaceutical compounds
GB0012291D0 (en) Pharmaceutical combination
GB0019228D0 (en) Novel pharmaceutical
GB0021865D0 (en) Novel pharmaceutical
GB0019272D0 (en) Pharmaceutical compounds
GB0014006D0 (en) Novel pharmaceutical
GB0024318D0 (en) Pharmaceutical compounds
GB0019224D0 (en) Novel pharmaceutical
GB0019226D0 (en) Novel pharmaceutical
GB0023971D0 (en) Novel pharmaceutical
GB0014005D0 (en) Novel pharmaceutical
GB0005382D0 (en) Pharmaceutical composition
GB0021487D0 (en) Pharmaceutical
GB0005366D0 (en) Pharmaceutical compounds
GB0023970D0 (en) Novel pharmaceutical
GB0021785D0 (en) Novel Pharmaceutical
GB0019223D0 (en) Novel pharmaceutical
GB0012293D0 (en) Pharmaceutical combination
EG24200A (en) Novel pharmaceutical
GB0031524D0 (en) Novel pharmaceutical
GB0031528D0 (en) Novel pharmaceutical
GB0031521D0 (en) Novel pharmaceutical

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)